Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorCairo University

About this trial

this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to mulligan therapy in symptomatic forward head posture.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

CVA equal or less than 50

Had cervical pain for more than three months and had visited an orthopedist clinic

Disqualifiers

cervical spine spondylosis

fractures or cervical spinal surgery

Cervical or shoulder neurological movement disorder.

Temporo-mandibular surgery, (5) Pathologic trauma

Trial design

Design model

Parallel

Treatments tested in this trial

  • Integrated Neuromuscular Inhibition Technique and mulligan therapy

    Other intervention

    patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique and mulligan therapy for limited cervical range of motion

  • Integrated Neuromuscular Inhibition Technique

    Other intervention

    patients will receive Integrated Neuromuscular Inhibition Technique in the form of intermittent ischemic compression, strain counter strain and muscle energy technique

  • mulligan therapy

    Other intervention

    patients will receive mulligan therapy for limited cervical range of motion

  • postural correction exercises

    Other intervention

    the patients will receive two strengthening exercises (deep cervical flexors and scapular retractors) and two stretching: cervical extensors (sub-occipital muscles) and pectoral muscles). The program was based on a program by Harman and Kendall

Treatment groups

120 Participants
are divided into 4 treatment groups
Group A: Integrated Neuromuscular Inhibition Technique and mulligan therapyExperimental treatment 2 interventions
Group B: Integrated Neuromuscular Inhibition TechniqueExperimental treatment 2 interventions
Group C: mulligan therapyExperimental treatment 2 interventions
Group D: postural correction exercisesActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

pain intensity

visual analogue scale will be used to asses pain intensity which patient will be instructed to put point on line from no pain to tolerable pain. The scale consists of a line, usually 100 mm long, ranging from no pain or discomfort (zero) , to the worst pain that could possibly feel

Time frame
up to six weeks

Secondary outcomes

1

neck disability

will be measured by Arabic neck disability index. It contains ten category/classes. Each category contains six choices (zero-five).Score from zero to four no disability, from five to 15 this is mild, From 15 to 24 this is moderate, from 25 to 34 this is severe, more than 34 this is a complete disability

Time frame
up to 6 weeks
2

pressure pain threshold

pressure pain threshold pressure pain threshold will be assessed by commander algometer

Time frame
up to six weeks
3

cervical range of motion

range of motion will be measured by inclinometer CROM. The CROM (deluxe version - Performance Attainment Associates, Roseville, MN, USA) measures the cervical range of motion5- for fexion, extension, lateral fexion, and rotation using separate inclinometers. These inclinometers are attached to a frame similar to that for eyeglasses one in the sagittal plane for fexion - extension, second in the frontal plane for lateral fexion and a third in the horizontal plane for rotation.

Time frame
up to six weeks
4

craniovertebral angle

The craniovertebral angle is identified as the intersection of a horizontal line passing through the C7 spinous process and a line joining the midpoint of the tragus of the ear to the skin overlying the C7 spinous process. it measured by photogrametric methods. when the angle less than or equal 50 degree

Time frame
up to six weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: